Adenovirus Testing Market Outlook 2025 to 2035
The Adenovirus Testing Market is expected to surge from USD 1,126.5 Million in 2025 to USD 2,343.4 Million by 2035, growing at a CAGR of 7.6%. Increasing incidence of respiratory, ocular, and gastrointestinal adenovirus infections is driving demand for high-sensitivity PCR and antigen-based diagnostic kits, particularly across hospitals, clinics, and research labs.
| Metric |
Value |
| Adenovirus Testing Market Estimated Value in (2025 E) |
USD 1126.5 million |
| Adenovirus Testing Market Forecast Value in (2035 F) |
USD 2343.4 million |
| Forecast CAGR (2025 to 2035) |
7.6% |
According to the latest research by Fact.MR, adenovirus testing market is set to witness a 6.9% growth during the year 2021-2031. The market is moderately fragmented and the demand for adenovirus testing will witness sharp growth owing to increasing need for early diagnosis of chronic diseases. Adenovirus prompts the most common respiratory outbreaks and diseases which occurs each year.
| Countries |
CAGR |
| United States |
8.1% |
| China |
7.8% |
| Germany |
7.2% |
| U.K. |
6.9% |
What is Driving Demand for Adenovirus Testing?
The rising number of adenovirus cases throughout the world is the primary factor driving the adenovirus testing market.
Detection of adenovirus is essential for choosing the most suitable treatment for the infection. Moreover, as adenovirus infection is related with many nonspecific manifestations and clinical syndromes, the detection only on clinical criteria is rather challenging. Because of this, there is an increase in demand for adenovirus testing kits, which boosts the market growth.
Research and development activities for developing new technologies for use in the detection of viral infections is growing, which drives the market development.
Increase in Adoption of Technologically Advanced Tests likely to boost Adenovirus Testing Sales
In order to provide a suitable treatment for adenovirus infection, early diagnosis is essential. Recently, cell culture is being used to detect adenovirus as it replicates efficiently in cell culture.
PCR methods for the detection of adenoviral DNA and its amplification by PCR is becoming a widely accepted method for the diagnosis of infection.
Especially, rapid identification and quantification of adenoviral DNA by methods such as PCR is anticipated to support the diagnosis and therapeutic monitoring of adenoviral infection, particularly in immunodeficient patients. This, sequentially, is projected to support the development of the market during the forecast years.
dPCR (Digital PCR) is developing as an essential clinical tool. Digital PCR is a novel approach to nucleic acid identification and quantification that provides a substitute method to traditional real-time quantitative PCR for complete quantification and rare allele identification. These advancements in the adenovirus detection techniques are expected to boost the market development.
US and Canada Adenovirus Testing Market Outlook
US dominates the global market over the forecast period, due to growth in public health concerns about infectious diseases like pneumonia. Pneumonia is considered to be related to adenovirus infection.
In addition, there are a number of private diagnostics laboratories and hospitals in the U.S. and Canada that provide a wide-ranging portfolio of tests to detect the existence of adenovirus. Also, rising demand for cutting-edge molecular diagnostic tests, technological advancement in molecular diagnostics and growth in the incidence of adenovirus infection are projected to boost the market for adenovirus Testing.
Europe Demand Outlook for Adenovirus Testing
Europe is expected to be second most lucrative region for market.? This growth is attributable to the opportunistic approach to increasing investments in the field of adenovirus testing and the presence of a rising number of key players.
Also, the growing living standards and an increase in geriatric population results into increased demand for chronic disease detection and management, the burden of diseases is changing. This is also leading to growth of the market.
Who are the Key Manufacturers and Suppliers of Adenovirus Testing?
Some of the leading manufacturers and suppliers of Adenovirus Testing include
- Affymetrix
- Agilent Technologies
- Becton Dickinson and company
- QIAGEN
- Novartis AG
- Bio-Rad Laboratories Inc.
- F. Hoffmann-La Roche AG
- Abbott Laboratories
- CTK Biotech Inc.
This market is highly competitive and is supported by widespread R&D initiatives. New product launches and advancements assists organizations with improving their geographical reach and current product portfolio. Manufacturer also focusing on enhancing the quality of their assays by conducted surveillance projects at different hospitals, which thus, is projected to create lucrative opportunities for the development of the market.
Adenovirus Testing Market Report Highlights
- Detailed overview of parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint
